Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations.
Fiche publication
Date publication
septembre 2018
Journal
BMC medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Covic A, Genovesi S, Rossignol P, Kalra PA, Ortiz A, Banach M, Burlacu A
Lien Pubmed
Résumé
The choice of the most appropriate antithrombotic regimen that balances ischemic and bleeding risks was addressed by the August 2017 European Society of Cardiologists (ESC)/European Association for Cardio-Thoracic Surgery Focused Update recommendations, which propose new evaluation scores and protocols for patients requiring a coronary stent or patients with an acute coronary syndrome, atrial fibrillation, or a high bleeding risk and indication for oral anticoagulation therapy.
Mots clés
Anticoagulation, Antithrombotics, Bleeding, Cardiovascular disease, Chronic kidney disease, Ischemic heart disease, Risk score
Référence
BMC Med. 2018 Sep 19;16(1):158